Lam Research Corporation $LRCX Shares Sold by EULAV Asset Management

Key Points

• EULAV Asset Management cut its Lam Research stake by 43% in the third quarter, selling 5,010 shares and retaining 6,643 shares valued at approximately $2.18 million.
• Other major institutional investors increased their positions, including State Street, Bank of America, Van ECK Associates and Amundi; institutional investors collectively own 84.61% of LRCX.
• Lam Research reported strong quarterly results, with revenue up 54.4% to $8.22 billion and adjusted EPS of $2.20, though supply constraints, declining China exposure and valuation concerns remain risks.

EULAV Asset Management reduced its holdings in Lam Research Corporation (NASDAQ:LRCX - Free Report) by 43.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,643 shares of the semiconductor company's stock after selling 5,010 shares during the period. EULAV Asset Management's holdings in Lam Research were worth $2,182,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. State Street Corp increased its holdings in shares of Lam Research by 2.6% in the 2nd quarter. State Street Corp now owns 60,704,130 shares of the semiconductor company's stock valued at $26,320,468,000 after purchasing an additional 1,545,830 shares during the period. Bank of America Corp DE boosted its position in Lam Research by 5.5% during the second quarter. Bank of America Corp DE now owns 11,244,147 shares of the semiconductor company's stock valued at $4,872,426,000 after purchasing an additional 584,489 shares during the last quarter. Van ECK Associates Corp grew its stake in Lam Research by 411.8% in the second quarter. Van ECK Associates Corp now owns 11,089,395 shares of the semiconductor company's stock valued at $4,805,368,000 after purchasing an additional 8,922,854 shares in the last quarter. Amundi grew its stake in Lam Research by 23.7% in the first quarter. Amundi now owns 10,147,479 shares of the semiconductor company's stock valued at $2,168,107,000 after purchasing an additional 1,942,862 shares in the last quarter. Finally, Janus Henderson Group PLC increased its position in Lam Research by 2.0% in the 1st quarter. Janus Henderson Group PLC now owns 9,265,026 shares of the semiconductor company's stock worth $1,975,244,000 after purchasing an additional 181,087 shares during the last quarter. 84.61% of the stock is owned by hedge funds and other institutional investors.

Key Stories Impacting Lam Research

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Record results and strong profitability: Fiscal first-quarter revenue rose 54.4% year over year to $8.22 billion, exceeding estimates, while adjusted EPS of $2.20 also beat forecasts. Operating margin topped 40% for the first time, supported by strong systems sales, memory demand and record foundry revenue. Lam Research Q1 Earnings Beat on Systems Sales and Margin Gains
• Positive Sentiment: Long-term AI and memory demand remains supportive: Lam expects wafer-fabrication-equipment spending to exceed $200 billion in 2027, driven by AI infrastructure, memory upgrades and advanced manufacturing. Customer Support revenue is expected to grow more than 30%, while Aether dry-resist revenue is projected to reach $2.5 billion cumulatively. LRCX Q1 Earnings Call Highlights
• Positive Sentiment: Some analysts remain bullish: Mizuho reiterated an Outperform rating and recommended buying the pullback, while Bank of America maintained a Buy rating. Erste Group also modestly increased its FY2027 and FY2028 EPS estimates. Mizuho recommends buying the pullback
• Neutral Sentiment: Guidance was broadly in line but leaves limited room for disappointment: Fiscal second-quarter revenue guidance of $8.2 billion-$9.0 billion and EPS guidance of $2.18-$2.48 bracket consensus estimates of $8.5 billion and $2.30, respectively. Mizuho trimmed its price target to $360 from $365, signaling continued upside but greater near-term caution.
• Negative Sentiment: Supply bottlenecks are limiting shipments: Component shortages and cleanroom capacity constraints could restrict equipment deliveries through 2027, preventing Lam from fully converting strong demand into revenue. Lam Research says supply bottlenecks are holding back revenue
• Negative Sentiment: China exposure and sector pressure are weighing on sentiment: China’s revenue contribution is expected to decline substantially from 35% in the September quarter. Citi warned of additional downside for Lam and peers, while a broad AI-chip sell-off amplified concerns about valuations and spending.

Insider Buying and Selling at Lam Research

In other news, insider Ava Harter sold 5,000 shares of the firm's stock in a transaction on Monday, August 31st. The shares were sold at an average price of $302.46, for a total value of $1,512,300.00. Following the sale, the insider owned 42,462 shares in the company, valued at approximately $12,843,056.52. This trade represents a 10.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Bethany Mayer sold 9,557 shares of the business's stock in a transaction on Wednesday, September 9th. The stock was sold at an average price of $314.74, for a total transaction of $3,007,970.18. Following the transaction, the director directly owned 20,995 shares in the company, valued at $6,607,966.30. This trade represents a 31.28% decrease in their position. The disclosure for this sale is available in the SEC filing. Company insiders own 0.31% of the company's stock.

Lam Research Price Performance

Shares of NASDAQ:LRCX opened at $230.10 on Monday. The company has a market cap of $287.43 billion, a price-to-earnings ratio of 34.29, a PEG ratio of 0.86 and a beta of 1.85. The business has a 50 day moving average price of $301.90 and a 200 day moving average price of $309.95. The company has a quick ratio of 1.86, a current ratio of 2.48 and a debt-to-equity ratio of 0.27. Lam Research Corporation has a twelve month low of $135.50 and a twelve month high of $438.50.

Lam Research (NASDAQ:LRCX - Get Free Report) last issued its quarterly earnings results on Wednesday, October 21st. The semiconductor company reported $2.20 EPS for the quarter, topping the consensus estimate of $2.18 by $0.02. The company had revenue of $8.22 billion for the quarter, compared to the consensus estimate of $8.14 billion. Lam Research had a return on equity of 72.15% and a net margin of 32.34%. The company's revenue for the quarter was up 54.4% on a year-over-year basis. During the same period in the previous year, the business posted $1.26 EPS. Research analysts predict that Lam Research Corporation will post 9.48 earnings per share for the current year.

Lam Research Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, October 14th. Stockholders of record on Wednesday, September 23rd were given a $0.33 dividend. This is a positive change from Lam Research's previous quarterly dividend of $0.26. This represents a $1.32 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend was Wednesday, September 23rd. Lam Research's dividend payout ratio (DPR) is currently 19.67%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on LRCX shares. UBS Group reaffirmed a "buy" rating and set a $400.00 price target (down from $425.00) on shares of Lam Research in a research note on Thursday. Morgan Stanley set a $339.00 price target on Lam Research and gave the company an "overweight" rating in a research note on Thursday. Wells Fargo & Company reissued an "overweight" rating and issued a $350.00 price target (down from $450.00) on shares of Lam Research in a research note on Thursday, July 30th. Mizuho dropped their price objective on Lam Research from $365.00 to $360.00 and set an "outperform" rating on the stock in a report on Thursday. Finally, Zacks Research lowered shares of Lam Research from a "strong-buy" rating to a "hold" rating in a research report on Thursday. Twenty-six equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $354.55.

Lam Research Profile

Lam Research Corporation NASDAQ: LRCX is a semiconductor equipment company that develops and manufactures systems used to fabricate integrated circuits. Its technologies support key stages of wafer processing, helping semiconductor manufacturers create the increasingly complex structures found in memory, logic and other types of chips.

The company's product portfolio includes etch systems, which selectively remove materials from wafers; deposition systems, which apply thin films; and cleaning solutions used to remove contaminants and residue during manufacturing.

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.